{"id":"https://openalex.org/W2017997790","doi":"https://doi.org/10.1007/s10067-009-1203-2","title":"Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials","display_name":"Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials","publication_year":2009,"publication_date":"2009-06-17","ids":{"openalex":"https://openalex.org/W2017997790","doi":"https://doi.org/10.1007/s10067-009-1203-2","mag":"2017997790","pmid":"https://pubmed.ncbi.nlm.nih.gov/19533210","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2721139"},"language":"en","primary_location":{"id":"doi:10.1007/s10067-009-1203-2","doi":"https://doi.org/10.1007/s10067-009-1203-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10067-009-1203-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10067-009-1203-2.pdf","source":{"id":"https://openalex.org/S44888363","display_name":"Clinical Rheumatology","issn_l":"0770-3198","issn":["0770-3198","1434-9949"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Rheumatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s10067-009-1203-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079748913","display_name":"Ernest Choy","orcid":"https://orcid.org/0000-0003-4459-8609","observed_orcids":["https://orcid.org/0000-0003-4459-8609"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Ernest H. S. Choy","raw_affiliation_strings":["Department of Rheumatology, Weston Education Centre, King's College London, London SE5 9RJ, UK. ernest.choy@kcl.ac.uk","Department of Rheumatology, Weston Education Centre, King\u2019s College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Weston Education Centre, King's College London, London SE5 9RJ, UK. ernest.choy@kcl.ac.uk","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Department of Rheumatology, Weston Education Centre, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081778211","display_name":"Philip J. Mease","orcid":"https://orcid.org/0000-0002-6620-0457","observed_orcids":["https://orcid.org/0000-0002-6620-0457"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210093417","display_name":"Swedish Medical Center","ror":"https://ror.org/004jktf35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093417","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip J. Mease","raw_affiliation_strings":["Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, USA","Swedish Medical Center and University of Washington School of Medicine, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210093417"]},{"raw_affiliation_string":"Swedish Medical Center and University of Washington School of Medicine, Seattle, USA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210093417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091037144","display_name":"Daniel K. Kajdasz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel K. Kajdasz","raw_affiliation_strings":["PGxHealth LLC, New Haven, CT, USA","PGxHealth LLC, New Haven, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PGxHealth LLC, New Haven, CT, USA","institution_ids":[]},{"raw_affiliation_string":"PGxHealth LLC, New Haven, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091578640","display_name":"Madelaine M. Wohlreich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madelaine M. Wohlreich","raw_affiliation_strings":["Lilly Research Laboratories, Indianapolis, IN, USA","Lilly Research Laboratories, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061223764","display_name":"Paul F. Crits-Christoph","orcid":"https://orcid.org/0000-0001-6858-8451","observed_orcids":["https://orcid.org/0000-0001-6858-8451"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Crits-Christoph","raw_affiliation_strings":["Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA","Department of Psychiatry , University of Pennsylvania , Philadelphia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Department of Psychiatry , University of Pennsylvania , Philadelphia, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102916328","display_name":"Daniel J. Walker","orcid":"https://orcid.org/0000-0002-9369-6953","observed_orcids":["https://orcid.org/0000-0002-9369-6953"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Walker","raw_affiliation_strings":["Lilly Research Laboratories, Indianapolis, IN, USA","Lilly Research Laboratories, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113683776","display_name":"Amy S. Chappell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy S. Chappell","raw_affiliation_strings":["Lilly Research Laboratories, Indianapolis, IN, USA","Lilly Research Laboratories, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5079748913"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":{"value":4890,"currency":"USD","value_usd":4890},"apc_paid":{"value":4890,"currency":"USD","value_usd":4890},"fwci":4.2522,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.94384875,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"28","issue":"9","first_page":"1035","last_page":"1044"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11282","display_name":"Fibromyalgia and Chronic Fatigue Syndrome Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11282","display_name":"Fibromyalgia and Chronic Fatigue Syndrome Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":1.0},{"id":"https://openalex.org/keywords/fibromyalgia","display_name":"fibromyalgia","score":1.0},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9639999866485596},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8859999775886536},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.722000002861023},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.7590000033378601},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.824999988079071},{"id":"https://openalex.org/keywords/discontinuation","display_name":"discontinuation","score":0.5410000085830688},{"id":"https://openalex.org/keywords/vital-signs","display_name":"vital signs","score":0.6190000176429749},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.9210000038146973},{"id":"https://openalex.org/keywords/suicide-related-behaviors","display_name":"suicide-related behaviors","score":0.7620000243186951},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.8803794384002686},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8539111614227295},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.8341608643531799},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7218896746635437},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6502512693405151},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6366814374923706},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6199625730514526},{"id":"https://openalex.org/C2910564767","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine Hydrochloride","level":4,"score":0.5819825530052185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5760571360588074},{"id":"https://openalex.org/C2777831278","wikidata":"https://www.wikidata.org/wiki/Q540571","display_name":"Fibromyalgia","level":2,"score":0.5311233997344971},{"id":"https://openalex.org/C2781112942","wikidata":"https://www.wikidata.org/wiki/Q178436","display_name":"Constipation","level":2,"score":0.44106799364089966},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005356","descriptor_name":"Fibromyalgia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s10067-009-1203-2","doi":"https://doi.org/10.1007/s10067-009-1203-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10067-009-1203-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10067-009-1203-2.pdf","source":{"id":"https://openalex.org/S44888363","display_name":"Clinical Rheumatology","issn_l":"0770-3198","issn":["0770-3198","1434-9949"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Rheumatology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2721139","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2721139","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Rheumatol","raw_type":"Text"},{"id":"pmid:19533210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19533210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical rheumatology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.356.7158","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.356.7158","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/f2/5a/Clin_Rheumatol_2009_Sep_18_28(9)_1035-1044.tar.gz","raw_type":"text"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/da24b4c8-006f-443d-8157-f91f7f273f2f","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/da24b4c8-006f-443d-8157-f91f7f273f2f","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Choy, E H S, Mease, P J, Kajdasz, D K, Wohlreich, M M, Crits-Christoph, P, Walker, D J & Chappell, A S 2009, 'Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials', Clinical rheumatology, vol. 28, no. 9, pp. 1035 - 1044. https://doi.org/10.1007/s10067-009-1203-2","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":{"id":"doi:10.1007/s10067-009-1203-2","doi":"https://doi.org/10.1007/s10067-009-1203-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10067-009-1203-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10067-009-1203-2.pdf","source":{"id":"https://openalex.org/S44888363","display_name":"Clinical Rheumatology","issn_l":"0770-3198","issn":["0770-3198","1434-9949"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Rheumatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017997790.pdf","grobid_xml":"https://content.openalex.org/works/W2017997790.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W60025275","https://openalex.org/W88010091","https://openalex.org/W106742613","https://openalex.org/W158070291","https://openalex.org/W1971393265","https://openalex.org/W1979796529","https://openalex.org/W1979917573","https://openalex.org/W1982721912","https://openalex.org/W1984259090","https://openalex.org/W1988347806","https://openalex.org/W1990079987","https://openalex.org/W1994201276","https://openalex.org/W1995650316","https://openalex.org/W2003924139","https://openalex.org/W2012033425","https://openalex.org/W2018366934","https://openalex.org/W2025763259","https://openalex.org/W2027717377","https://openalex.org/W2033577846","https://openalex.org/W2038995778","https://openalex.org/W2040163165","https://openalex.org/W2040179400","https://openalex.org/W2041481324","https://openalex.org/W2043595892","https://openalex.org/W2047902057","https://openalex.org/W2048519309","https://openalex.org/W2049756500","https://openalex.org/W2065649431","https://openalex.org/W2069090735","https://openalex.org/W2069238845","https://openalex.org/W2069923031","https://openalex.org/W2076728061","https://openalex.org/W2084168719","https://openalex.org/W2085189002","https://openalex.org/W2089857290","https://openalex.org/W2093196756","https://openalex.org/W2098748546","https://openalex.org/W2106059433","https://openalex.org/W2114824785","https://openalex.org/W2118879709","https://openalex.org/W2128447164","https://openalex.org/W2135582867","https://openalex.org/W2138512124","https://openalex.org/W2159484656","https://openalex.org/W2253364553","https://openalex.org/W2320909684","https://openalex.org/W2341970774","https://openalex.org/W2346744058"],"related_works":["https://openalex.org/W1971489430","https://openalex.org/W2113214053","https://openalex.org/W2027717377","https://openalex.org/W7100652674","https://openalex.org/W6902337323","https://openalex.org/W2128447164","https://openalex.org/W1981808732","https://openalex.org/W2038995778","https://openalex.org/W1971313899","https://openalex.org/W2080874313"],"abstract_inverted_index":{"The":[0,65,110,238],"purpose":[1],"of":[2,12,19,112,151,194,212],"this":[3],"report":[4],"is":[5],"to":[6,52,106,131,155],"describe":[7],"the":[8,126,135,159,165,224,229],"overall":[9],"safety":[10,38,246],"profile":[11,111],"both":[13],"short-":[14,243],"and":[15,34,63,90,103,122,163,171,189,203,244],"longer-term":[16],"duloxetine":[17,73,180,219,255,268],"treatment":[18,71,137,161,226],"fibromyalgia.":[20,257],"Data":[21],"from":[22,247],"four":[23,232],"double-blind,":[24],"randomized,":[25],"placebo-controlled":[26,225],"studies":[27,162,250],"(two":[28],"with":[29,72,139,182,208,221,254,267],"6-month":[30],"open-label":[31,37],"extension":[32],"phases)":[33],"a":[35,146,175],"1-year,":[36],"study":[39],"were":[40,74,104,169,191,206],"included.":[41],"Safety":[42],"measures":[43,205],"included":[44],"treatment-emergent":[45,195],"adverse":[46,49,55,113,142,156,264],"events":[47,50,56,114,143,157,265],"(TEAEs),":[48],"leading":[51],"discontinuation,":[53],"serious":[54],"(SAEs),":[57],"clinical":[58,249],"laboratory":[59],"tests,":[60],"vital":[61,187,200],"signs,":[62],"electrocardiograms.":[64],"most":[66],"common":[67],"TEAEs":[68,100],"for":[69,123,179,218,256,263],"short-term":[70,136,160],"nausea":[75],"(29.3%),":[76],"headache":[77],"(20.0%),":[78],"dry":[79],"mouth":[80],"(18.2%),":[81],"insomnia":[82],"(14.5%),":[83,87],"fatigue":[84],"(13.5%),":[85],"constipation":[86],"diarrhea":[88],"(11.6%),":[89],"dizziness":[91],"(11.0%;":[92],"all":[93],"p":[94],"<":[95],"0.05":[96],"vs.":[97],"placebo).":[98],"Most":[99],"emerged":[101],"early":[102],"mild":[105],"moderate":[107],"in":[108,115,125,134,158,164,186,223,251,269,272],"severity.":[109],"patients":[116,124,152,233,252],"enrolled":[117],"at":[118,145,174],"least":[119],"6":[120],"months,":[121],"1-year":[127,166,230],"study,":[128,231],"was":[129],"similar":[130],"that":[132],"found":[133],"studies,":[138],"no":[140],"new":[141],"emerging":[144],"notable":[147],"rate.":[148],"About":[149],"20%":[150],"discontinued":[153],"due":[154],"study.":[167],"SAEs":[168],"uncommon,":[170],"none":[172],"occurred":[173],"significantly":[176,216],"higher":[177,217],"frequency":[178],"compared":[181,220],"placebo.":[183],"Mean":[184],"changes":[185],"signs":[188],"weight":[190],"small.":[192],"Rates":[193],"potentially":[196],"clinically":[197],"significant":[198],"(PCS)":[199],"sign,":[201],"laboratory,":[202],"electrocardiogram":[204],"low,":[207],"only":[209],"PCS":[210],"rates":[211],"alanine":[213],"aminotransferase":[214],"being":[215],"placebo":[222],"studies.":[227],"In":[228,258],"(1.1%)":[234],"had":[235],"suicide-related":[236],"behavior.":[237],"data":[239],"provided":[240],"here":[241],"summarize":[242],"long-term":[245],"five":[248],"treated":[253],"addition,":[259],"postmarketing":[260],"surveillance":[261],"continues":[262],"reported":[266],"fibromyalgia,":[270],"as":[271],"other":[273],"indications.":[274]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}